CLINICAL AND IMMUNOLOGICAL EFFECTS OF NILOTINIB IN COMBINATION WITH PEGYLATED INTERFERON-A2B IN PATIENTS WITH SUBOPTIMAL MOLECULAR RESPONSE ON IMATINIB (NORDDUTCHCML009)

I. Geelen, U. Olsson-Stromberg, S. Mustjoki, J. Richter, N. Blijlevens, W. Smit, B. Gjertsen, T. Gedde-Dahl, B. Markevarn, M. Koppes, P. Westerweel, J. Janssen, H. Hjorth-Hansen

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Original languageEnglish
JournalHaematologica
Volume102
Pages (from-to)435-435
Number of pages1
ISSN0390-6078
Publication statusPublished - 26 Jun 2017
Event22nd Congress of the European-Hematology-Association - Madrid, Spain
Duration: 22 Jun 201725 Jun 2017

Cite this

Geelen, I. ; Olsson-Stromberg, U. ; Mustjoki, S. ; Richter, J. ; Blijlevens, N. ; Smit, W. ; Gjertsen, B. ; Gedde-Dahl, T. ; Markevarn, B. ; Koppes, M. ; Westerweel, P. ; Janssen, J. ; Hjorth-Hansen, H. / CLINICAL AND IMMUNOLOGICAL EFFECTS OF NILOTINIB IN COMBINATION WITH PEGYLATED INTERFERON-A2B IN PATIENTS WITH SUBOPTIMAL MOLECULAR RESPONSE ON IMATINIB (NORDDUTCHCML009). In: Haematologica. 2017 ; Vol. 102. pp. 435-435.
@article{076ca056d0e9491d91ef88aa6cde6f86,
title = "CLINICAL AND IMMUNOLOGICAL EFFECTS OF NILOTINIB IN COMBINATION WITH PEGYLATED INTERFERON-A2B IN PATIENTS WITH SUBOPTIMAL MOLECULAR RESPONSE ON IMATINIB (NORDDUTCHCML009)",
author = "I. Geelen and U. Olsson-Stromberg and S. Mustjoki and J. Richter and N. Blijlevens and W. Smit and B. Gjertsen and T. Gedde-Dahl and B. Markevarn and M. Koppes and P. Westerweel and J. Janssen and H. Hjorth-Hansen",
year = "2017",
month = "6",
day = "26",
language = "English",
volume = "102",
pages = "435--435",
journal = "Haematologica",
issn = "0390-6078",
publisher = "FERRATA STORTI FOUNDATION",

}

Geelen, I, Olsson-Stromberg, U, Mustjoki, S, Richter, J, Blijlevens, N, Smit, W, Gjertsen, B, Gedde-Dahl, T, Markevarn, B, Koppes, M, Westerweel, P, Janssen, J & Hjorth-Hansen, H 2017, 'CLINICAL AND IMMUNOLOGICAL EFFECTS OF NILOTINIB IN COMBINATION WITH PEGYLATED INTERFERON-A2B IN PATIENTS WITH SUBOPTIMAL MOLECULAR RESPONSE ON IMATINIB (NORDDUTCHCML009)' Haematologica, vol. 102, pp. 435-435.

CLINICAL AND IMMUNOLOGICAL EFFECTS OF NILOTINIB IN COMBINATION WITH PEGYLATED INTERFERON-A2B IN PATIENTS WITH SUBOPTIMAL MOLECULAR RESPONSE ON IMATINIB (NORDDUTCHCML009). / Geelen, I.; Olsson-Stromberg, U.; Mustjoki, S.; Richter, J.; Blijlevens, N.; Smit, W.; Gjertsen, B.; Gedde-Dahl, T.; Markevarn, B.; Koppes, M.; Westerweel, P.; Janssen, J.; Hjorth-Hansen, H.

In: Haematologica, Vol. 102, 26.06.2017, p. 435-435.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

TY - JOUR

T1 - CLINICAL AND IMMUNOLOGICAL EFFECTS OF NILOTINIB IN COMBINATION WITH PEGYLATED INTERFERON-A2B IN PATIENTS WITH SUBOPTIMAL MOLECULAR RESPONSE ON IMATINIB (NORDDUTCHCML009)

AU - Geelen, I.

AU - Olsson-Stromberg, U.

AU - Mustjoki, S.

AU - Richter, J.

AU - Blijlevens, N.

AU - Smit, W.

AU - Gjertsen, B.

AU - Gedde-Dahl, T.

AU - Markevarn, B.

AU - Koppes, M.

AU - Westerweel, P.

AU - Janssen, J.

AU - Hjorth-Hansen, H.

PY - 2017/6/26

Y1 - 2017/6/26

M3 - Meeting Abstract

VL - 102

SP - 435

EP - 435

JO - Haematologica

JF - Haematologica

SN - 0390-6078

ER -